Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and …

EP Baron - Headache: The Journal of Head and Face Pain, 2018 - Wiley Online Library
Background Comprehensive literature reviews of historical perspectives and evidence
supporting cannabis/cannabinoids in the treatment of pain, including migraine and …

From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology

A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …

[HTML][HTML] Cannabinoids and epilepsy

EC Rosenberg, RW Tsien, BJ Whalley, O Devinsky - Neurotherapeutics, 2015 - Elsevier
Cannabis has been used for centuries to treat seizures. Recent anecdotal reports,
accumulating animal model data, and mechanistic insights have raised interest in cannabis …

Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it's been…

EP Baron - Headache: The Journal of Head and Face Pain, 2015 - Wiley Online Library
Background The use of cannabis, or marijuana, for medicinal purposes is deeply rooted
though history, dating back to ancient times. It once held a prominent position in the history …

The endocannabinoid system of animals

RJ Silver - Animals, 2019 - mdpi.com
Simple Summary Our understanding of the Endocannabinoid System of animals, and its
ubiquitous presence in nearly all members of Animalia, has opened the door to novel …

Cannabis and the brain

L Iversen - Brain, 2003 - academic.oup.com
The active compound in herbal cannabis, Δ9‐tetrahydrocannabinol, exerts all of its known
central effects through the CB1 cannabinoid receptor. Research on cannabinoid …

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation

BG Ramírez, C Blázquez, TG Del Pulgar… - Journal of …, 2005 - Soc Neuroscience
Alzheimer9s disease (AD) is characterized by enhanced β-amyloid peptide (βA) deposition
along with glial activation in senile plaques, selective neuronal loss, and cognitive deficits …

Phytocannabinoids as novel therapeutic agents in CNS disorders

AJ Hill, CM Williams, BJ Whalley… - Pharmacology & …, 2012 - Elsevier
The Cannabis sativa herb contains over 100 phytocannabinoid (pCB) compounds and has
been used for thousands of years for both recreational and medicinal purposes. In the past …

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

D Panikashvili, C Simeonidou, S Ben-Shabat, L Hanuš… - Nature, 2001 - nature.com
Traumatic brain injury triggers the accumulation of harmful mediators that may lead to
secondary damage,. Protective mechanisms to attenuate damage are also set in motion. 2 …

Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures—a short review

I Svíženská, P Dubový, A Šulcová - Pharmacology Biochemistry and …, 2008 - Elsevier
In the last 25 years data has grown exponentially dealing with the discovery of the
endocannabinoid system consisting of specific cannabinoid receptors, their endogenous …